The management outcome of heart failure reduced ejection fraction with or without angiotensin receptor neprilysin inhibitor in Kelantan

被引：0
|
作者：
Wu, J. T. [1 ]
Othman, M. K. [1 ]
Isa, W. Y. H. W. [1 ]
机构：
[1] Hosp Univ Sains Malaysia, Cardiol Unit, Kota Baharu, Kelantan, Malaysia
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2022年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
10
引用
收藏
页码：5 / 6
页数：2
相关论文
共 50 条
  • [31] Effects of angiotensin receptor neprilysin inhibition on pulmonary arterial stiffness in heart failure with reduced ejection fraction
    Yenercag, Mustafa
    Arslan, Ugur
    Dereli, Seckin
    Coksevim, Metin
    Dogdus, Mustafa
    Kaya, Ahmet
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2021, 37 (01): : 165 - 173
  • [32] Timing of angiotensin receptor-neprilysin inhibitor initiation in patients with heart failure and reduced ejection fraction: data from the Swedish heart failure registry
    Stolfo, D.
    Lund, L.
    Benson, L.
    Kack, O.
    Lindberg, F.
    Sinagra, G.
    Dahlstrom, U.
    Savarese, G.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [33] Soluble neprilysin predicts outcome in patients with heart failure with reduced ejection fraction
    Pavo, N.
    Wurm, R.
    Korn, S.
    Osorio, E.
    Huelsmann, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S325 - S325
  • [34] Comparative analysis of renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor and mineralocorticoid receptor antagonists in heart failure with mildly reduced ejection fraction
    Lin, T.
    Kuan, D. W. K.
    Lee, C. C. L.
    Wu, W. C. K.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [35] Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction
    Lee, Chia-Chen
    Kuan, David Te-Wei
    Chang, Kai-Chun
    Chen, Zheng-Wei
    Cheng, Jen-Fang
    Lin, Ting-Tse
    Lin, Lian-Yu
    Wu, Cho-Kai
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [36] Effects of the angiotensin receptor-neprilysin inhibitor/sacubitril-valsartan administration on quality of life and outcome in heart failure with reduced ejection fraction: a meta analysis
    Dewi, Kadek Intan Murti
    Pintaningrum, Yusra
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)
  • [37] Angiotensin Receptor-neprilysin Inhibitor Therapy is Associated With Improved Echocardiographic Parameters in Chronic Heart Failure Patients With Reduced Ejection Fraction
    Poglajen, Gregor
    Drofenik, Ajda Anzic
    Jurca, Dominika
    Zemljic, Gregor
    Cerar, Andraz
    Okrajsek, Renata
    Sebestjen, Miran
    Frljak, Sabina
    Vrtovec, Bojan
    CIRCULATION, 2019, 140
  • [38] Estimated plasma volume in heart failure with reduced ejection fraction: ACE inhibitors versus angiotensin receptor/neprilysin inhibitor in follow up
    Varga, S.
    Antolkovic, L.
    Zeljkovic, I
    Pavlovic, N.
    Jordan, A.
    Pavlov, M.
    Vitlov, P.
    Rudan, D.
    Novak, A.
    Lisnjic, P.
    Manola, S.
    Jurin, I
    EUROPEAN HEART JOURNAL, 2024, 45
  • [39] Clinical and Socioeconomic Determinants of Angiotensin Receptor-Neprilysin Inhibitor Prescription at Hospital Discharge in Patients With Heart Failure With Reduced Ejection Fraction
    Tran, Jeffrey S.
    Loveland, Macklin G.
    Alamer, Ahmad
    Pina, Ileana L.
    Sweitzer, Nancy K.
    CIRCULATION-HEART FAILURE, 2022, 15 (11) : E009395
  • [40] Outcomes of Angiotensin Receptor-Neprilysin Inhibitor Prescriptions for Patients with Heart Failure and Reduced Ejection Fraction in Real World Clinical Practice
    Malloy, Rhynn J.
    Smith, Katelyn V.
    Stern, Gretchen M.
    Desai, Akshay S.
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S28 - S28
12345